Congress Speakers


The LSX World Congress USA is a CxO level conference and attracts high-quality speakers from investors, biotechs and pharma creating an agenda to educate investors and corporates on the most exciting new technology and therapeutic areas in healthcare today.

Laurent Audoly, President & CEO, Kymera Therapeutics

Laurent Audoly
President & CEO, Kymera Therapeutics
Kymera Therapeutics

Jake Becraft, Co-founder, CEO, Strand Therapeutics

Jake Becraft
CEO, Strand Therapeutics

Strand Therapeutics

Jeff Behrens, President & CEO, Siamab Therapeutics

Jeff Behrens
President & CEO, Siamab Therapeutics

Siamab Therapeutics

Laura Benjamin, Founder & CEO, Oncologie

Laura Benjamin
Founder & CEO, Oncologie

Oncologie

David De Graaf, CEO, Comet Therapeutics

David De Graaf
CEO, Comet Therapeutics

Comet Therapeutics

Peter Dudek, Partner, MRL Ventures Fund

Peter Dudek
Partner, MRL Ventures Fund
MRL Ventures Fund

Melissa Fensterstock, Co-Founder and CEO, Landsdowne Labs

Melissa Fensterstock
Co-Founder & CEO, Landsdowne Labs
Landsdowne Labs

Meredith Fisher, Partner, Partners Innovation Fund, Partners Healthcare

Meredith Fisher
Partner, Partners Innovation Fund, Partners Healthcare

Partners Healthcare

Todd Foley, Managing Partner, MPM Capital

Todd Foley
Managing Partner, MPM Capital
MPM Capital

John Glasspool, CEO, Anthos Therapeutics

John Glasspool
CEO, Anthos Therapeutics

Anthos Therapeutics

Kelly Gold, VP, Corporate Development, CAMP4 Therapeutics

Kelly Gold
VP, Corporate Development, CAMP4 Therapeutics
CAMP4 Therapeutics

Dan Grau, CEO, Sojournix

Dan Grau
CEO, Sojournix
Sojournix

Adam Houghton, Vice President and Head, AbbVie Ventures

Adam Houghton
VP & Head, AbbVie Ventures
AbbVie Ventures

Nouhad Husseini, VP, Head of Business Development, Regeneron Pharmaceuticals

Nouhad Husseini
VP, Head of Business Development, Regeneron Pharmaceuticals

Regeneron Pharmaceuticals 300x

Ed Kaye, CEO, Stoke Therapeutics

Ed Kaye
CEO, Stoke Therapeutics

Stoke Therapeutics 300x

Nicole Kholodnov, VP of Clinical Operations, Parsley Health

Nicole Kholodnov
VP of Clinical Operations, Parsley Health
Parsley Health

Philippe Lopes-Fernandes, SVP, Global Head of BD & Alliance Management, Merck Serono

Philippe Lopes-Fernandes
VP, Global Head of BD & Alliance Management, Merck Serono

Merck Serono 300x

Michael Pavin, CEO, Tuned Therapeutics

Michael Pavin
CEO, Tuned Therapeutics

Veronique Riethuisen, SVP, Global Head of Business Development & Alliance Management, Ipsen

Veronique Riethuisen
SVP, Global Head of Business Development & Alliance Management, Ipsen

Ipsen Ventures 300x

Priyanka Rohatgi, Managing Director, Head, Ipsen Ventures

Priyanka Rohatgi
Managing Director, Head, Ipsen Ventures
Ipsen Ventures

Adam Rosenberg, President & CEO, Rodin Therapeutics

Adam Rosenberg
President & CEO, Rodin Therapeutics
Rodin Therapeutics

Nigel Sheail, Global Head of Mergers & Acquisitions and Business Development & Licensing, Novarits

Nigel Sheail
Global Head of M&A & Business Development & Licensing, Novartis

Novarits 300x

Marshall Smith, Head of Global Healthcare, Goldman Sachs

Marshall Smith
Head of Global Healthcare, Goldman Sachs
Goldman Sachs

Jay Stamatis, Vice President, Head of Business Development and Acquisitions, Abbvie 300x

Jay Stamatis
VP, Head of Business Development & Acquisitions, Abbvie
AbbVie Ventures 300x

Ricky Sun, Partner, Life Sciences, Bain Capital

Ricky Sun
Partner, Life Sciences, Bain Capital
Bain Capital

Ted Tanner Jr., CTO and Chief Architect, Watson Health, IBM (1)

Ted Tanner Jr.
CTO & Chief Architect, Watson Health, IBM
IBM

Rogerio Vivaldi, CEO, Sigilon Therapeutics

Rogerio Vivaldi
CEO, Sigilon Therapeutics
Sigilon Therapeutics

Joel Wishkovsky, CEO, Simple Health

Joel Wishkovsky
CEO, Simple Contacts
Simple Contacts 300x

Carolyn Witte, Co-Founder and CEO, Tia

Carolyn Witte
Co-Founder & CEO, Tia
Tia 300x

Beyhan Zaim, SVP, Commercial Business Development, Novo Nordisk

Beyhan Zaim
SVP, Commercial Business Development, Novo Nordisk

Novo Nordisk 300x

Alan Crane, Entrepreneur Partner, Polaris Partners

Alan Crane
Entrepreneur Partner, Polaris Partners
Polaris Partners

Joshua Resnick, Managing Partner, RA Capital Management

Joshua Resnick
Managing Partner, RA Capital Management
RA Capital Management

DOWNLOAD THE BROCHURE